Jeffrey A. Munsie
General Counsel bei CONCERT PHARMACEUTICALS, INC.
Profil
Jeffrey A.
Munsie is currently the Chief Legal Officer at Concert Pharmaceuticals, Inc. Prior to his current position, he served as the SVP, Head-Operations & General Counsel at Merrimack Pharmaceuticals, Inc. from 2017 to 2019.
Before that, he worked as Counsel at Wilmer Cutler Pickering Hale & Dorr LLP from 2002 to 2011.
Mr. Munsie completed his undergraduate studies at Dartmouth College and obtained his graduate degree from Harvard Law School.
Aktive Positionen von Jeffrey A. Munsie
| Unternehmen | Position | Beginn |
|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | General Counsel | 23.09.2019 |
Ehemalige bekannte Positionen von Jeffrey A. Munsie
| Unternehmen | Position | Ende |
|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Geschäftsführer | 01.07.2019 |
Wilmer Cutler Pickering Hale & Dorr LLP
 Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | General Counsel | 01.01.2011 |
Ausbildung von Jeffrey A. Munsie
| Harvard Law School | Graduate Degree |
| Dartmouth College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Commercial Services |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
